Abstract Body

Background:

Early-onset diastolic dysfunction has emerged as a major threat to healthy aging in people with HIV-1 infection. Women living with HIV-1 infection (WLWH) are especially vulnerable and develop a unique pattern vascular and myocardial ischemia compared to men. Animal models that recapitulate this pathophysiology remain unreported, and this has left a void in our understanding of the molecular causes of the disease and treatment strategies to alleviate it.

Methods:

Female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ humanized mice (Hu-mice) were infected with HIV-1ADA and treated for fourteen weeks with dolutegravir (DTG)/tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) starting two weeks of infection. In vivo echocardiography was used to assess cardiac function and dimensions. Photoacoustic imaging was used to assess saturated oxygenated hemoglobin in the anterior wall of the heart, Prior to sacrifice, animals were intravenously injected with the fluorescent dye BSA-FITC and hearts were excised and evaluated for microvascular leakage/density of perfused microvessels, and fibrosis. Western blot assays and immunofluorescence and biochemical assays were also conducted.

Results:

At the end of the protocol, echocardiography revealed E:A, E:e’, left atria volume, global longitudinal and right ventricular diameter-systole increased by 32.1±5.1%, 28.2±5.6 %, 26.6±4.2, 32.5±4.3% and 19.6±1.3%, respectively in Hu-mice treated DTG/TDF/FTC compared to uninfected controls. Photoacoustic imaging also showed a 30.4±6.8% reduction in saturated oxygenated hemoglobin in the anterior wall of the heart. Ex vivo analyses of hearts from DTG/TDF/FTC-treated HIV mice revealed a 37.3±8.2% reduction in intact microvessels, a 30.6±6.2% reduction in the density of perfused microvessels with regions of micro-ischemia There were also 20.2±1.2 and 20.6± .3 % increases in interstitial and perivascular fibrosis, respectively. Expression of hypoxia-induced transcription factor HIF-1α was increased 2.6±0.5-fold, the cytotoxic glycolysis metabolite, methylglyoxal (MG) was increased 3.2±0.3-fold and the inflammation-induced protein, vascular adhesion protein-1 was increased 123.5±10% in hearts of HIV-infected female Hu-mice compared to uninfected controls

Conclusions:

These new data show that HIV-infected Hu-mice treated with DTG/TDF/FTC can recapitulate the diastolic dysfunction, microvascular dysfunction, and hypoxia/ischemia seen in WLHV. It also provides a model to study diastolic dysfunction in HIV infection. R01HL164306